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Background: Different single-stage surgical approaches are currently under evaluation to repair cartilage focal
lesions. To date, only little is known on even short-term clinical follow-up and almost no knowledge exists on
histological results of such treatments. The present paper aims to analyze the clinical and histological results of
the collagen-covered microfracture and bone marrow concentrate (C-CMBMC) technique in the treatment of
focal condylar lesions of knee articular cartilage.
Methods: Nine patients with focal lesions of the condylar articular cartilage were consecutively treated with
arthroscopic microfractures (MFX) covered with a collagenmembrane immersed in autologous bonemarrow con-
centrate (BMC) from the iliac crest. Patients were retrospectively assessed using several standardized outcome as-
sessment tools and MRI scans. Four patients consented to undergo second look arthroscopy and biopsy harvest.
Results: Every patient was arthroscopically treated for a focal condylar lesion (mean area 2.5 SD(0.4) cm2).
All the patients (mean age 43 SD(9) years) but one experienced a signiﬁcant clinical improvement from
the pre-operative condition to the latest follow-up (mean 29 SD(11) months). Cartilage macroscopic
assessment at 12 months revealed that all the repairs appeared almost normal. Histological analysis
showed a hyaline-like cartilage repair in one lesion, a ﬁbrocartilaginous repair in two lesions and a mixture
of both in one lesion.
Conclusions: The ﬁrst clinical experience with single-stage C-CMBMC for focal cartilage defects in the knee
suggests that it is safe, it improves the short-term knee function and that it has the potential to recreate
hyaline-like cartilage.
Level of evidence: IV, case series.© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Focal cartilage defects are a common cause of knee symptoms and
disability and may progress to osteoarthritis (OA) [1,2]. To be effective
a cartilage repair procedure should recreate hyaline-like cartilage and
ultimately prevent OA [3].
The limits of the microfracture (MFX) treatment with respect to
lesion size and to long term functional improvements [3,4] and the
high cost and the need for two operations of the autologous chondro-
cyte implantation (ACI) and ACI-related procedures [5] have prompted
the search for new one-step cartilage repair methods. Autologous
matrix-induced chondrogenesis (AMIC) has emerged as a new technique
adopting a collagenic scaffold combined with microfractures [6]. Similar
procedures have been developed, adopting synthetic polymers like
polyglycolic acid (PGA)/hyaluronan in combination with microfracture
and have shown the potential to restore hyaline-like cartilage [7–9].396902546 (mobile).
. This is an open access article underIn all these techniques microfracture should permit the migration of
mesenchymal stem cells (MSCs) from the subchondral bone, and
the scaffold should keep cells in situ and serve as support for tissue
differentiation.
The intra-articular delivery of bone marrow concentrate (BMC)
and marrow aspirate improved the outcomes of microfracture in full
thickness cartilage defect in the horse model [10] and in the goat
model [11] respectively. This observation may be possibly explained
by the fact that the BMC from the iliac crest contains higher concentra-
tion of MSCs with respect to tibial or femoral bone marrow blood, and
with greater doubling potential [12]. This observation has led tomodiﬁ-
cations to the original single-stage technique involving the addition of
BMC to treat talar osteochondral lesions [13].
In the present study cartilage lesions have been treated with the
association of MFX, BMC from the iliac crest and a collagenic coverage
scaffold. The aim of this study was to analyze clinical and histological
outcomes of collagen-covered microfracture and bonemarrow concen-
trate (C-CMBMC) for the treatment of patientswith full-thickness, focal,
condylar knee cartilage defect.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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2.1. Study design
From February 2008 to March 2011, nine consecutive patients with
symptomatic chondral lesions of the knee underwent all-arthroscopic
C-CMBMC. After ethical committee approval, full informed consent
was obtained from each patient. Inclusion criteria were: lesion
size≥ 1.5 cm2, age ≤ 60, chondral defect Outerbridge type III or IV, ad-
herence to the rehabilitation protocol, full anagraphics available, signed
consent, and full surgeon report available. Exclusion criteria were
tibiofemoral or patellofemoral malalignment, knee instability, kissing
lesions, advanced OA, rheumatic, metabolic or neoplastic diseases.
Every patient, after informed consent, was asked to undergo a second
look arthroscopy with biopsy for assessing the state of the repair at 12
month follow-up. Failurewas deﬁned as the need of a new surgical pro-
cedure to treat persisting pain or effusion in the previously operated
knee. Patients were retrospectively analyzed with standardized assess-
ment tools such as the International Knee Documentation Committee
(IKDC) score, the Lysholm score the VAS and the Tegner activity scale.
Patients were also evaluated with MRI scans at variable follow-up.
2.2. Surgical technique
The CMBMC surgical technique has been described in detail by
Gigante et al. [14]. Brieﬂy, a small area over the iliac crest donor site
was draped. After diagnostic arthroscopy to conﬁrm the indication for
the procedure a 2.5 mm Jamshidi needle was inserted percutaneously
into the iliac crest. Sixty milliliters of bone marrow blood were aspirated
and processedwith theMarrowStimConcentration kit (Biomet,Warsaw,
IN) according to the manufacturer's instructions, obtaining 3–4 mL of
BMC.
The chondral lesion was debrided and microfractures were
performed using appropriate awls. The lesion main dimensions were
measured and reported on a rubber template that was then adjusted
to the exact shape of the defect. A Biocollagen MeRG® collagen mem-
brane (Bioteck, Vicenza, Italy) was cut to match the defect shape and
immersed in BMC until implantation.
The water ﬂowwas stopped and water was aspirated from the joint
cavity. A 10:one mixture of 1–2 mL ﬁbrin glue and BMC was laid on the
lesion bed using a long needle. Themembranewas inserted through the
appropriate portal with a grasper and ﬁtted into place with a probe. An
additional 2–3 mL of the ﬁbrin glue-BMCmixture was injected over the
membrane and left to solidify for 2–3 min. Finally, the excess of the ﬁ-
brin glue-BMC mixture was removed and the knee repeatedly ﬂexed
and extended to check membrane stability.
The patients started continuous passivemotion ondays 4–5 and par-
tial weight-bearing at 3 weeks, progressing to full weight-bearing at 6
weeks. Isometric quadriceps and hamstrings training and straight leg
raising were advised during the non-weight-bearing period. Light
sports activities such as swimming, cycling or jogging on even softFig. 1. Second-look arthroscopy and biopsy harvest. a) The Jamshidi needle is inserted from the
repair in level with the surrounding cartilage, completely integrated, with a smooth surface a
minute ﬁssurations.ground were allowed at 6 months. Permission to participate in unre-
stricted sports activity was given after 12 months.
2.3. Second-look arthroscopy
Four patients consented to second-look arthroscopy and biopsy
harvest. Biopsies were performed with a standard 2.5 mm diameter
Jamshidi needle (Fig. 1a). The specimens were placed in 10% formalin
and sent for histology processing. The quality of the implanted tissue
was evaluated by the surgeon using the criteria of the International
Cartilage Repair Society [15] Cartilage Repair Assessment (CRA) [15].
2.4. Histology
Histological and histochemical characteristics of the repair tissue
were evaluated. Specimens were decalciﬁed, parafﬁn-embedded and
stained with Safranin-O to detect the presence of glycosaminoglycans.
Polarized microscopy was used to discriminate between hyaline-like
cartilage and ﬁbrocartilage. The ICRS II Histology Scoring System [16]
was used to evaluate the quality of the repair tissue. Histological evalu-
ation was performed blindly by two different investigators and scores
were averaged.
2.5. Statistical analysis
The Student t-test was performed for the IKDC score, the Lysholm
score and the VAS to compare pre- and postoperative values. Data are
expressed as means with standard deviations. The nonparametric
Wilcoxon-signed rank test was performed for the Tegner activity scale
to compare pre- and postoperative values. Data are expressed as me-
dians and interquartile ranges. For all tests, p b 0.05 was considered
signiﬁcant. The statistical software SPSS (Version 17.0) was used for
biometric analysis.
3. Results
3.1. Clinical outcome
Nopatient-related complicationsnor device-related complicationswere encountered.
None of the patients was lost at follow-up. All patients followed the standardized rehabil-
itation protocol. Patients' characteristics and patient-reported outcomes are shown in
Table 1. Associated intervention at the time of surgerywas two (one partialmeniscectomy
and one synovectomy). A patient with an unshouldered cartilage defect required a mini-
arthrotomy to ﬁx the membrane with polar stitches.
A statistically signiﬁcant improvement in the mean IKDC subjective score from
49 SD(11) to 82 SD(12), mean Lysholm score from 58 SD(13) to 88 SD(11) and mean
VAS from 7.6 SD(1) to 2.3 SD(2.2) from preoperative values to the latest follow-up were
obtained (p b 0.05) (see Table 1 for single values). The median Tegner activity scale
showed no signiﬁcant difference from pre-injury level of 4 (interquartile range 4–7) to
post-operative level of 4 (interquartile range 3.5–6.5) at latest follow-up (p N 0.05) (see
Table 1 for single values). On the other hand, a signiﬁcant increase in the activity level
from post-injury 2 (interquartile range 2–3) to post-operative was observed at latest
follow-up (p b 0.05).appropriate portal and the bioptic cylinder is harvested. b) Second look biopsy showing a
nd a slightly ﬁbrillated border. c) Repair in level, with a slightly demarcating border and
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32 D. Enea et al. / The Knee 22 (2015) 30–35One patient (# 9) has met the deﬁnition of failure, having undergone a successive
surgical procedure for persisting effusion. The patient underwent another cartilage repair
procedure in the lateral femoral condyle at another institution; this patient (latest
VAS=2, latest Lysholm 82)was not in pain and had a signiﬁcant improvement frombase-
line (VAS 7, Lysholm 58), however complained frequent knee effusions after practicing
competitive soccer. Another patient (# 7) who did not meet the deﬁnition of failure had
a worsening of pain and symptoms from baseline (VAS 6, Lysholm 75) to the latest
follow-up (VAS 8, Lysholm 68). However his knee function was improved after a cycle of
intra-articular platelet rich plasma injections.
Three post-operative MRI scans were retrieved with a mean of 7 SD(1.5) month
follow-up (range 6–9 months). They have showed in all cases the reconstitution of
the original cartilage level (Fig. 2). Similarly, bone marrow edema and/or subchondral
irregularities were observed in all the cases (Fig. 2). Non-homogeneous cartilage signal
was observed in two out of three cases; ﬁssurations were noted in two out of three
cases, surface irregularities in one out of three cases.
3.2. Arthroscopic evaluation
At the time of the second-look arthroscopy (Fig. 1) all the patients but one were
asymptomatic. According to the ICRS CRA evaluation all the four C-CMBMC patients
were classiﬁed as nearly normal (grade 2), the median of the overall assessment being
9.5 (range 9–11).
3.3. Histological evaluation
According to the ICRS II score, the four C-CMBMC biopsies scored amean overall of 64
SD(13), with a mean tissue morphology of 63 SD(19). Hyaline-like matrix was found in
only one case (Fig. 3d), ﬁbrocartilage was found in two cases (Fig. 3a, c) and a mixture
of hyaline/ﬁbrocartilage was found in one case (Fig. 3b), with hyaline-like cartilage next
to the osteochondral junction (Fig. 3j) and ﬁbrocartilage next to the articular surface
(Fig. 3f). Even when hyaline-like cartilage was found, the columnar cell arrangement
typical of normal articular cartilagewas never observed (Fig. 3d). The collagenmembrane
was completely reabsorbed in all the bioptic samples cases.
4. Discussion
With a mean of 29 months follow-up, the C-CMBMC technique was
shown to be safe and effective in improving symptoms of patients
affected by isolated condylar cartilage lesions, and has the potential to
induce hyaline-like cartilage repair.
In recent years one-step cartilage repair has become increasingly
adopted to treat chondral knee defects [8,9,17–20]. The diverse tech-
niques in use mainly differ for the type of scaffold adopted (collagenic
[6,17,19,20] or PGA/hyaluronan based [8,9,18]), for the eventual platelet
rich plasma (PRP) augmentation [8,17] and for the surgical approach
(arthroscopic [8,9,17] or mini-open [8,9,17–20]).
The original AMIC (autologous matrix-induced chondrogenesis) as-
sociated MFX, a porcine collagen type I/III membrane and the injection
of ﬁbrin mixed with autologous serum underneath the scaffold [21].Fig. 2. Postoperative MRI scans representative of the average quality of cartilage repair. a,
b) The T1 coronal and sagittal sections (6 months post-operatively) of the left knee show
complete defect ﬁlling of the medial compartment defect (arrows), isointense cartilage
signal, minor subchondral junction irregularities and the presence of small bone cysts.
Moderate marrow edema was visible with T2 sequences (not shown). The patient (48
years old at the time of the C-CMBMC procedure) had previously undergone both
microfracture and a ACI procedure on the same site.
Fig. 3. Biopsies stained with Safranin-O. Each column represents a single biopsy; lines a–d represent the entire bioptic cylinder; lines e–h represent the chondral matrix; and lines i–l
represent the osteochondral junction. Biopsies a and c represent a ﬁbrocartilaginous repair. Cells are in fact clearly chondrocytes, but collagen ﬁbers can be seen runningwithin thematrix
in different directions (e, g). It has to be noted that the thickness of biopsy c is reduced. Biopsy d represents hyaline-like cartilage repair. It shows chondrocytes in large, round lacunae and a
glassy matrix with a metachromatic staining for Safranin-O (h) and tide mark reconstitution (l, arrows). Biopsy b represents a mixed hyaline-like/ﬁbrocartilaginous repair where
ﬁbrocartilage may be observed toward the articular surface (f) and a glassy matrix with the tide mark reconstitution may be observed close to the osteochondral junction (j, arrows).
Picture d shows large clefts in the chondral substance which may be artifacts from biopsy harvesting or sample cutting.
33D. Enea et al. / The Knee 22 (2015) 30–35Large (mean area 4 cm2) chondral defects have been treated with such
technique obtaining a signiﬁcant clinical improvement at an average of
37month follow-up. However, the quality of the regenerated tissue and
the level of tissue ﬁlling were not ideal. Around one out of three MRI
scans revealed incomplete defect ﬁlling and subchondral bone abnor-
malities [6].
Kusano et al., in a retrospective study on autologousmatrix-induced
chondrogenesis (AMIC) did not observed a signiﬁcant clinical improve-
ment in patients treated for condylar cartilage defects.Moreover, half of
the patients treated for patellar defects required mobilization under
anesthesia due to knee stiffness. The authors found inconsistent tissue
regeneration. MRI scans revealed some complete ﬁlling, some empty
defect and some hypertrophic repair [20].
Efe et al. reported on the prospective clinical and MRI follow-up of a
three-dimensional collagen gel. The surgical technique did not involve
microfracture and relied on chondrocytemigration from the surroundinghealthy cartilage. The authors treated 1 cm2 lesions and reported signif-
icant clinical and MRI improvements [19].
Siclari et al. treated 52 patients with the association of subchondral
perforations and PRP-augmented PGA/hyaluronan scaffold. The authors
reported a statistically signiﬁcant clinical improvement at 12 month
follow-up [8]. Dhollander et al. reported on a pilot study on the associ-
ation ofmicrofracture and a PGA/hyaluronan coverage scaffold enriched
by autologous serum. The authors observed noticeable clinical im-
provement, however MRI scans revealed different percentages of
incomplete ﬁlling, subchondral bone irregularities, subchondral cysts
and intralesional osteophytes [18]. The same group analyzed patients
treated with the original AMIC technique in association with PRP.
Again, the favorable clinical outcomes were not matched by MRI im-
provements. At 2 years follow-up the authors reported persistence of
subchondral bone abnormalities, incomplete ﬁlling or hypertrophy of
the repair and intralesional osteophyte formation [17].
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the same CMBMC technique adopting a PGA/hyaluronan scaffold rather
than a collagen membrane, showing good clinical and functional
outcome [22].
In the present study the C-CMBMC patients obtained a statistically
signiﬁcant improvement in all the analyzed assessment tools frombase-
line to the latest follow-up. MRI scans commonly revealed the persis-
tence of bone marrow edema and subchondral plate irregularities, but
also showed a complete defect ﬁll in all the cases (Fig. 2). Overall one
patient, required a successive surgical intervention to treat persistence
of knee effusions the day after practicing competitive soccer. This pa-
tient was not in pain having a VAS of 2 at latest follow-up. However
this or a higher percentage of reoperations must be expected when
performing cartilage repair procedures [17,18,20,23,24].
More recently peripheral blood progenitor cells or cultured MSCs
have been associated with MFX with or without a coverage scaffold to
treat knee cartilage defects [25–27]. These procedures have demon-
strated to be safe and effective, however they require a ﬁrst step for
the Filgrastim administration and plasma apheresis or for the surgical
marrow blood harvest, cell sorting and subsequent culture. Therefore
these are not single-stage procedures, require two steps, autologous
cell manipulation and are expensive. Moreover the indication for
these procedures needs to be conﬁrmed with a previous diagnostic
arthroscopy.
Only a few studies have investigated the histological outcomes
of one-step procedures in the treatment of articular cartilage lesions
[7,8,13,28]. In particular, Giannini et al., associated BMC and PRP gel
with a hyaluronic acid membrane or collagen powder to treat talar
osteochondral lesions. In this study a functional improvement was ob-
served for all the patients, and three biopsies harvested showed differ-
ent degrees of tissue remodeling toward hyaline-like cartilage [13].
Siclari et al. performed 10 second look arthroscopies harvesting ﬁve bi-
opsies. Macroscopic observation showed a whiter appearance of the re-
pairs, a certain degree of hypertrophy and surface irregularity.
Histological evaluation uniformly showed hyaline-like cartilage repair
with good subchondral integration [8]. In the present study a nearly
normal appearance of the repaired tissue was documented according
to the ICRS CRA (Fig. 1b, c). The histological analysis revealed one
hyaline-like repair, one mixture of ﬁbrocartilage and hyaline-like carti-
lage and two ﬁbrocartilaginous repairs (Fig. 3). The percentage of
hyaline-like repair in this study is in line with that previously reported
for ACI and ACI-related procedures [29,30]. The mean overall ICRS II
score of both treatment groups of 64 SD(13) is in line with the one re-
cently reported for ACI-related procedures and higher than that report-
ed for microfracture [3,29]. These histological results indicate that cells
derived from autologous BMC and seeded on a scaffold may differenti-
ate into mature chondrocytes and produce a ﬁbrocartilaginous and/or
hyaline extracellular matrix when applied in human adult articular car-
tilage lesions. In particular the presence of hyaline-like cartilage next to
the osteochondral junction in the mixed hyaline/ﬁbrocartilage repair
(Fig. 3b, f, j) could indicate progressive bottom-to-top cartilage remod-
eling and maturation [31,32]. These in vivo observations conﬁrmed
some in vitro results that demonstrated that human MSCs from bone
marrow aspirate can proliferate on collagen scaffolds and differentiate
into chondrocytes without growth factor supplementation [33]. Even
though both MFX procedures and one-step procedures adopting scaf-
folds have been associated with bone osteophytes formation on the
bed of the lesion [17,18], this was not observed in our patient group
neither arthroscopically nor histologically. Since the addition of BMC
to the mentioned procedures could theoretically increase this possibili-
ty, a longer follow-up is mandatory to explore the potential onset of
such bone hypertrophy.
The mean age of the overall population was 43 SD(9) years (range
28–53). Therefore it may be hypothesized that some degree of degener-
ative changes occurred at least in some of the patients. However, carti-
lage repair techniques have been adopted to treat patients with earlyOA, demonstrating the capability to improve the symptoms and delay
the need for prosthetic replacement [34]. Moreover, if compared to
the original ACI, one-step procedures are relatively inexpensive and
have been used in older patients (up to 65 years-old) providing pain
relief and good histological results [8].
Limitations of this study are small sample size, lack of control group,
and short-term follow up. Moreover the patients were not stratiﬁed for
presence of early OA with preoperative plain X-ray. The strength of the
present study is that isolated condylar lesions of similar size were treat-
ed in the absence of limbmalalignment andmajor associated confound-
ing procedures such as ACL reconstruction or unloading osteotomies.
This study also provides biopsies which represent an objective assess-
ment of the C-CMBMC cartilage repair capabilities.
In summary our clinical and histological data suggest that the
arthroscopically performed C-CMBMC procedurewas safe and provided
short-term signiﬁcant pain relief and functional improvement. A nearly
normal arthroscopic appearance of the repair and the potential to
regenerate hyaline-like cartilage were documented. A complete ﬁll of
the defect was shown by MRI imaging and second-look arthroscopies.
A complete re-evaluation of the patients with MRI, functional scores
and failure rate has been planned at 5 years follow-up.
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